(4-(N-(5-Cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)benzofuran-6-yl)methylsulfonamido)-2-fluorophenyl)boronic acid

ID: ALA4548919

PubChem CID: 71263635

Max Phase: Preclinical

Molecular Formula: C26H23BF2N2O6S

Molecular Weight: 540.35

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(c3ccc(B(O)O)c(F)c3)S(C)(=O)=O)c(C3CC3)cc12

Standard InChI:  InChI=1S/C26H23BF2N2O6S/c1-30-26(32)24-19-12-18(14-3-4-14)22(13-23(19)37-25(24)15-5-7-16(28)8-6-15)31(38(2,35)36)17-9-10-20(27(33)34)21(29)11-17/h5-14,33-34H,3-4H2,1-2H3,(H,30,32)

Standard InChI Key:  ISLVVWCDXMALMX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   14.8168   -4.3253    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2295   -5.0352    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.6379   -4.3228    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.6478   -4.2180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6467   -5.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3547   -5.4465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3529   -3.8091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0616   -4.2144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0618   -5.0376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8448   -5.2917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.3285   -4.6256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8444   -3.9598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1424   -4.6239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5507   -5.3331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3671   -5.3331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7763   -4.6248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3631   -3.9149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5480   -3.9183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0966   -3.1826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8959   -3.0124    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.1482   -2.2351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5496   -2.5755    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.5935   -4.6234    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.9380   -3.8063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5292   -3.0987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1208   -3.8065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9386   -5.4456    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.5232   -5.4444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9379   -6.2628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2277   -6.6657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2267   -7.4821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9346   -7.8921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6450   -7.4798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6425   -6.6647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3538   -7.8865    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.9349   -8.7093    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
   15.2274   -9.1182    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.6428   -9.1176    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 11 13  1  0
 12 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  2  0
 16 23  1  0
 25 24  1  0
 26 25  1  0
 24 26  1  0
  4 24  1  0
  5 27  1  0
 27  2  1  0
  2 28  1  0
 27 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 33 35  1  0
 32 36  1  0
 36 37  1  0
 36 38  1  0
M  END

Associated Targets(non-human)

NS5B Hepatitis C virus NS5B RNA-dependent RNA polymerase (3026 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 540.35Molecular Weight (Monoisotopic): 540.1338AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Chong PY, Shotwell JB, Miller J, Price DJ, Maynard A, Voitenleitner C, Mathis A, Williams S, Pouliot JJ, Creech K, Wang F, Fang J, Zhang H, Tai VW, Turner E, Kahler KM, Crosby R, Peat AJ..  (2019)  Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor.,  62  (7): [PMID:30763090] [10.1021/acs.jmedchem.8b01719]

Source